title: Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials.
authors.affiliation: From the Department of Neurology, The University of Texas Medical School at Houston (S.I.S.); Department of Anatomy and Neurobiology, University of California, Irvine (S.C.C.); and Department of Neurology, University of Pittsburgh, PA (L.W.).
authors.forename: Sean I
authors.initials: SI
authors.lastname: Savitz
authors.forename: Steven C
authors.initials: SC
authors.lastname: Cramer
authors.forename: Lawrence
authors.initials: L
authors.lastname: Wechsler
mesh_terms: D015415:Biomarkers; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D023381:Endpoint Determination; D006801:Humans; D018579:Patient Selection; D033581:Stem Cell Transplantation / Q000379:methods; D013234:Stem Cells / Q000502:physiology*; D020521:Stroke / Q000628:therapy*; D000071939:Stroke Rehabilitation
chemical_list: D015415:Biomarkers
keywords: guideline; stem cells; stroke